Benvic, a French group leader in production of highly innovative PVC-based thermoplastic solutions and ecological biopolymers, has announced the acquisition of the majority of Luc & Bel, a group specialising in the design and manufacture of components of excellence for medical devices.
via Shutterstock
Benvic acquires majority share in Luc & Bel
Benvic thus further strengthens its position in the medical sector, where the group is present following investment in Modenplast, a PVC producer specialising in the production of formulations, tubes and tubulars for medical use. Furthermore, the operation will enable Luc & Bel to accelerate the growth path by exploiting the many synergies that will be established with Modenplast itself and the international presence of the Benvic Group.
Luc & Bel uses state-of-the-art technologies and has a team with more than thirty years of experience to offer a range of high-quality medical products ranging from individual components to complete devices.
The transaction represents the seventh acquisition of Benvic in Europe. Of these, four took place in Italy.
Luc Mertens, CEO of Benvic, said: "We are very pleased to continue our growth path with Luc & Bel just one year after our first acquisition in the medical sector. PVC plays a fundamental role in this sector and this is why we aim to be increasingly present, starting from Italy. We are confident that Luc & Bel, thanks to its highly technological and innovative business model, will bring added value to our group and our customers".
Luca Ferrari, CEO of Luc & Bel, added: "We are thrilled to have joined Benvic Group which we are confident will further strengthen Luc & Bel's positioning internationally. We will continue to work guaranteeing our customers the high standards that distinguish us and, taking advantage of the new synergies that we will create together with Benvic, we will continue our growth path."